Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
M&A Fireworks: Shire Buys Jerini For €328 Million
03 Jul 2008
•
By
Jessica Merrill
Jerini secures a hefty payout, despite FDA deeming HAE candidate Firazyr “not approvable.”
More from Archive
More from Pink Sheet